AMA
Mushtaq S, Dogra D, Dogra N. A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India. Dermatology Review/Przegląd Dermatologiczny. 2024;111(3):179-185. doi:10.5114/dr.2024.144650.
APA
Mushtaq, S., Dogra, D., & Dogra, N. (2024). A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India. Dermatology Review/Przegląd Dermatologiczny, 111(3), 179-185. https://doi.org/10.5114/dr.2024.144650
Chicago
Mushtaq, Sabha, Devraj Dogra, and Naina Dogra. 2024. "A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India". Dermatology Review/Przegląd Dermatologiczny 111 (3): 179-185. doi:10.5114/dr.2024.144650.
Harvard
Mushtaq, S., Dogra, D., and Dogra, N. (2024). A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India. Dermatology Review/Przegląd Dermatologiczny, 111(3), pp.179-185. https://doi.org/10.5114/dr.2024.144650
MLA
Mushtaq, Sabha et al. "A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India." Dermatology Review/Przegląd Dermatologiczny, vol. 111, no. 3, 2024, pp. 179-185. doi:10.5114/dr.2024.144650.
Vancouver
Mushtaq S, Dogra D, Dogra N. A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India. Dermatology Review/Przegląd Dermatologiczny. 2024;111(3):179-185. doi:10.5114/dr.2024.144650.
